Variant report
Variant | esv3398511 |
---|---|
Chromosome Location | chr10:96870662-96876860 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537019721 | chr10:96870676-96870677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186114133 | chr10:96870686-96870687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111433382 | chr10:96870713-96870714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565768338 | chr10:96870714-96870715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150989972 | chr10:96870755-96870756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77402853 | chr10:96870759-96870760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539535301 | chr10:96870760-96870761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181468809 | chr10:96870801-96870802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552795449 | chr10:96870806-96870807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186503404 | chr10:96870822-96870823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536263782 | chr10:96870827-96870828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555345666 | chr10:96870851-96870852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191344440 | chr10:96870879-96870880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1854029 | chr10:96870913-96870914 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs183059499 | chr10:96870946-96870947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185834972 | chr10:96871033-96871034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190933025 | chr10:96871043-96871044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548533340 | chr10:96871055-96871056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568125023 | chr10:96871060-96871061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371953536 | chr10:96871152-96871153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146223275 | chr10:96871200-96871201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183074435 | chr10:96871244-96871245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548883284 | chr10:96871300-96871301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562196237 | chr10:96871305-96871306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187957098 | chr10:96871307-96871308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550600024 | chr10:96871353-96871354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570508863 | chr10:96871392-96871393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192190035 | chr10:96871396-96871397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546656061 | chr10:96871439-96871440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566681864 | chr10:96871455-96871456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61310181 | chr10:96871469-96871470 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs10882540 | chr10:96871506-96871507 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs575493586 | chr10:96871540-96871541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538136969 | chr10:96871696-96871697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557816473 | chr10:96871699-96871700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370139058 | chr10:96871706-96871707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547357306 | chr10:96871773-96871774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs56979418 | chr10:96871781-96871782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs560259788 | chr10:96871845-96871846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75342347 | chr10:96871851-96871852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542016122 | chr10:96871875-96871876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182770390 | chr10:96871888-96871889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562297198 | chr10:96871944-96871945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147768533 | chr10:96871975-96871976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550840861 | chr10:96872002-96872003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564155742 | chr10:96872004-96872005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533129904 | chr10:96872011-96872012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546692989 | chr10:96872032-96872033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188087782 | chr10:96872125-96872126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7072133 | chr10:96872142-96872143 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21364760 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:96869000-96871600 | Enhancers | HepG2 | liver |
2 | chr10:96871600-96876200 | Weak transcription | HepG2 | liver |
3 | chr10:96874800-96875200 | Enhancers | Liver | Liver |
4 | chr10:96875200-96876200 | Flanking Active TSS | Liver | Liver |
5 | chr10:96876200-96876600 | Enhancers | Liver | Liver |
6 | chr10:96876200-96877400 | Enhancers | HepG2 | liver |
7 | chr10:96876600-96876800 | Flanking Active TSS | Liver | Liver |
8 | chr10:96876800-96877000 | Enhancers | Liver | Liver |